Short Bowel Syndrome (SBS) Drugs Market Report

Global and China Short Bowel Syndrome (SBS) Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 20, 2022
  • PAGES：198
  • REPORT CODE：GMM1392876
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Short Bowel Syndrome (SBS) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Nutrinia

    • Emmaus Medical

    • Ardelyx

    • OxThera

    • Merck

    • Zealand Pharma

    • Naia Pharmaceuticals

    • Sancilio Pharmaceuticals

    • Shire

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Glucagon-Like Peptide-2 (GLP-2)

    • Growth Hormone

    • Glutamine

    • Other

    Application:

    • Hospitals

    • Clinics

    • Retail Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Short Bowel Syndrome (SBS) Drugs Industry Overview

      • 1.1.1 Short Bowel Syndrome (SBS) Drugs Market Scope and Market Segments

      • 1.1.2 Short Bowel Syndrome (SBS) Drugs Industry Characteristics

      • 1.1.3 Global and China Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Short Bowel Syndrome (SBS) Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Glucagon-Like Peptide-2 (GLP-2)

      • 1.2.2 Growth Hormone

      • 1.2.3 Glutamine

      • 1.2.4 Other

    • 1.3 Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Retail Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Short Bowel Syndrome (SBS) Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Short Bowel Syndrome (SBS) Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Short Bowel Syndrome (SBS) Drugs Industry PEST Analysis

    • 2.3 Short Bowel Syndrome (SBS) Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Short Bowel Syndrome (SBS) Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Short Bowel Syndrome (SBS) Drugs Industry

    Chapter 3 Global and China Short Bowel Syndrome (SBS) Drugs Market, by Manufacturer

    • 3.1 Global and China Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Short Bowel Syndrome (SBS) Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Short Bowel Syndrome (SBS) Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Short Bowel Syndrome (SBS) Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Short Bowel Syndrome (SBS) Drugs Market Top 3 Players

    Chapter 4 Global and China Short Bowel Syndrome (SBS) Drugs Market, by Type (2017-2028)

    • 4.1 Short Bowel Syndrome (SBS) Drugs Market Trend, by Type

    • 4.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Short Bowel Syndrome (SBS) Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Short Bowel Syndrome (SBS) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Short Bowel Syndrome (SBS) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Short Bowel Syndrome (SBS) Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Short Bowel Syndrome (SBS) Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Short Bowel Syndrome (SBS) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Short Bowel Syndrome (SBS) Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Short Bowel Syndrome (SBS) Drugs Market Analysis

    • 7.1 North America Short Bowel Syndrome (SBS) Drugs Market, by Type

    • 7.2 North America Short Bowel Syndrome (SBS) Drugs Market, by Application

    • 7.3 North America Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Short Bowel Syndrome (SBS) Drugs Market Analysis

    • 8.1 Europe Short Bowel Syndrome (SBS) Drugs Market, by Type

    • 8.2 Europe Short Bowel Syndrome (SBS) Drugs Market, by Application

    • 8.3 Europe Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Short Bowel Syndrome (SBS) Drugs Market Analysis

    • 9.1 APAC Short Bowel Syndrome (SBS) Drugs Market, by Type

    • 9.2 APAC Short Bowel Syndrome (SBS) Drugs Market, by Application

    • 9.3 APAC Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Short Bowel Syndrome (SBS) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Short Bowel Syndrome (SBS) Drugs Company Profiles

      • 11.1 Nutrinia

        • 11.1.1 Nutrinia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.1.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Emmaus Medical

        • 11.2.1 Emmaus Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.2.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ardelyx

        • 11.3.1 Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.3.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 OxThera

        • 11.4.1 OxThera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 OxThera Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.4.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Merck

        • 11.5.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Merck Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.5.3 Merck Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Zealand Pharma

        • 11.6.1 Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.6.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Naia Pharmaceuticals

        • 11.7.1 Naia Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.7.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Sancilio Pharmaceuticals

        • 11.8.1 Sancilio Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Shire

        • 11.9.1 Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Shire Short Bowel Syndrome (SBS) Drugs Product Profiles, Application and Specification

        • 11.9.3 Shire Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Short Bowel Syndrome (SBS) Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Short Bowel Syndrome (SBS) Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Short Bowel Syndrome (SBS) Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Glucagon-Like Peptide-2 (GLP-2) (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Growth Hormone (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Glutamine (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure North America Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Short Bowel Syndrome (SBS) Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Short Bowel Syndrome (SBS) Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Short Bowel Syndrome (SBS) Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Short Bowel Syndrome (SBS) Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Short Bowel Syndrome (SBS) Drugs Market Share, by Manufacturer in 2022

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Type (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Price Trend, by Type (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Value, by Type (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Price Trend, by Type (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Application (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Application (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Value, by Application (2017-2028)

    • Table China Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table North America Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table North America Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Short Bowel Syndrome (SBS) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Short Bowel Syndrome (SBS) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Nutrinia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nutrinia Product Profiles, Application and Specification

    • Table Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emmaus Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emmaus Medical Product Profiles, Application and Specification

    • Table Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx Product Profiles, Application and Specification

    • Table Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OxThera Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OxThera Product Profiles, Application and Specification

    • Table OxThera Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zealand Pharma Product Profiles, Application and Specification

    • Table Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Naia Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Naia Pharmaceuticals Product Profiles, Application and Specification

    • Table Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sancilio Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sancilio Pharmaceuticals Product Profiles, Application and Specification

    • Table Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shire Product Profiles, Application and Specification

    • Table Shire Short Bowel Syndrome (SBS) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US